Oral Oncology
Volume 46, Issue 4 , Pages 249-254 , April 2010

Impact of second primary esophageal or lung cancer on survival of patients with head and neck cancer

  • Min-Chi Chen

      Affiliations

    • Department of Public Health and Biostatistics Consulting Center, School of Medicine, Chang Gung University, Tao-Yuan, Taiwan
    • ,
  • Wei-Chao Huang

      Affiliations

    • Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan
    • Department of Medicine, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Tao-Yuan, Taiwan
    • ,
  • Chunghuang Hubert Chan

      Affiliations

    • Department of Hematology and Oncology, Chang Gung Memorial Hospital, Chiayi, Taiwan
    • Chang Gung Institute of Technology, Chiayi, Taiwan
    • ,
  • Ping-Tsung Chen

      Affiliations

    • Department of Medicine, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Tao-Yuan, Taiwan
    • Department of Hematology and Oncology, Chang Gung Memorial Hospital, Chiayi, Taiwan
    • ,
  • Kuan-Der Lee

      Affiliations

    • Department of Medicine, Graduate Institute of Clinical Medical Sciences, Chang Gung University, Tao-Yuan, Taiwan
    • Department of Hematology and Oncology, Chang Gung Memorial Hospital, Chiayi, Taiwan
    • Chang Gung Institute of Technology, Chiayi, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Department of Hematology and Oncology, Chang Gung Memorial Hospital, 6 West Sec., Chia-Pu Road, Pu-Tz city, Chiayi 613, Taiwan. Tel.: +886 5 3621000x2772; fax: +886 5 3623781.

Received 12 November 2009 ,Revised 28 December 2009 ,Accepted 4 January 2010.

References 

  1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49(1):33–64
  2. Licciardello JT, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys. 1989;17(3):467–476
  3. Rennemo E, Zatterstrom U, Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2063 cases. Laryngoscope. 2008;118(8):1350–1356
  4. Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994;74(7):1933–1938
  5. Tsou YA, Hua CH, Tseng HC, Lin MH, Tsai MH. Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otolaryngol. 2007;127(6):651–657
  6. Hong WK, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323(12):795–801
  7. Chen MC, Feng IJ, Lu CH, Chen CC, Lin JT, Huang SH, et al. The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003). Ann Oncol. 2008;19(6):1180–1186
  8. Tepperman BS, Fitzpatrick PJ. Second respiratory and upper digestive tract cancers after oral cancer. Lancet. 1981;2(8246):547–549
  9. Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008;123(10):2390–2396
  10. Slee VN. The international classification of diseases: ninth revision (ICD-9). Ann Intern Med. 1978;88(3):424–426
  11. Parkin DM, Muir CS. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ. 1992;(120):45–173
  12. Cox DR. Regression models and life tables. J Roy Stat Soc Ser B. 1972;(34):187–220
  13. Cox DR. Partial likelihood. Biometrika. 1975;62:269–276
  14. Lee KD, Lu CH, Chen PT, Chan CH, Lin JT, Huang CE, et al. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period. BMC Cancer. 2009;9:373–383
  15. D′Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papilloma virus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–1956
  16. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papilloma virus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709–720
  17. Chien YC, Chen JY, Liu MY, Yang HI, Hsu MM, Chen CJ, et al. Serologic markers of Epstein–Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med. 2001;345(26):1877–1882
  18. Cooper JS, Pajak TF, Rubin P, Tupchong L, Brady LW, Leibel SA, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys. 1989;17(3):449–456
  19. Day GL, Blot WJ, Shore RE, Schoenberg JB, Kohler BA, Greenberg RS, et al. Second cancers following oral and pharyngeal cancer: patients’ characteristics and survival patterns. Eur J Cancer B Oral Oncol. 1994;30B(6):381–386
  20. Rafferty MA, O’Dwyer TP. Secondary primary malignancies in head and neck squamous cell carcinoma. J Laryngol Otol. 2001;115(12):988–991
  21. Lee KD, Chen SC, Chan CH, Lu CH, Chen CC, Lin JT, et al. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2647–2655
  22. Schaapveld M, Visser O, Louwman MJ, de Vries EG, Willemse PH, Otter R, et al. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J Clin Oncol. 2008;26(8):1239–1246

PII: S1368-8375(10)00003-5

doi: 10.1016/j.oraloncology.2010.01.002

Oral Oncology
Volume 46, Issue 4 , Pages 249-254 , April 2010

Article Tools

* Image Usage & Resolution